BioSpace News Archive

Moderna, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending a variation to the conditional marketing authorization to include a 25 µg two-dose series of Spikevax for active immunization to prevent coronavirus disease 2019 caused by SARS-CoV-2 in children 6 months to 5 years.

Moderna, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing authorization for mRNA-1273.222 as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older, who have previously received at least a primary vaccination course against COVID-19.

Senior leaders of Florida Cancer Specialists & Research Institute will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21.

Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the publication of Phase 3 clinical data in the Journal of the American Medical Association (JAMA), highlighting that the clinical benefits of investigational therapeutic SER-109 for preventing recurrent C. difficile infection (rCDI) were apparent as early as two weeks post-treatment and sustained for at least 24 weeks.

Rho, a full-service contract research organization with a proven track record of drug development success, announced the appointment of J. Marc Pipas, MD, a leading oncologist, as Senior Medical Director.

Vivasc Therapeutics Inc. is pleased to announce it has initiated its second NIH Phase I STTR research grant, in conjunction with Georgetown University.

According to Nova one advisor, the global Smart Drug Delivery Systems market size was valued at USD 8.12 billion in 2022 and is predicted to hit USD 36.9 billion by 2030 with a registered CAGR of 15.9% during the forecast period 2022 to 2030.

According to Nova one advisor, the global Non-invasive Prenatal Testing market size was valued at USD 2.9 billion in 2021 and is predicted to hit USD 8.14 billion by 2030 with a registered CAGR of 14.9% during the forecast period 2022 to 2030.

According to Nova one advisor, the global Magnetic Resonance Imaging market size was valued at USD 7.9 billion in 2022 and is predicted to hit USD 10.17 billion by 2030 with a registered CAGR of 4.9% during the forecast period 2022 to 2030

The global Ablation Technology market gathered revenue around USD 4.9 Billion in 2020 and market is set to grow USD 11.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 13.9% during the prediction period 2021 to 2027.